Cargando…
Inhibiting HDAC1 Enhances the Anti-Cancer Effects of Statins through Downregulation of GGTase-Iβ Expression
Hydroxy-methyl-glutaryl-coenzyme A (HMG-CoA) reductase inhibitors, namely statins, are potential anti-tumor agents. Previously, we showed that a pan-histone deacetylase (HDAC) inhibitor enhances the anti-tumor effects of the HMG-CoA inhibitor. However, the underlying mechanisms were not fully unders...
Autores principales: | Li, Ran, Gan, Ye-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454923/ https://www.ncbi.nlm.nih.gov/pubmed/28481295 http://dx.doi.org/10.3390/ijms18051010 |
Ejemplares similares
-
GGTase3 is a Newly Identified Geranylgeranyltransferase Targeting a Ubiquitin Ligase
por: Kuchay, Shafi, et al.
Publicado: (2019) -
Neuronal cholesterol metabolism increases dendritic outgrowth and synaptic markers via a concerted action of GGTase-I and Trk
por: Moutinho, Miguel, et al.
Publicado: (2016) -
Molecular docking and simulation of Curcumin with Geranylgeranyl Transferase1 (GGTase1) and Farnesyl Transferase (FTase)
por: Subramani, Parasuraman Aiya, et al.
Publicado: (2015) -
A Homology Based Model and Virtual Screening of Inhibitors for Human Geranylgeranyl Transferase 1 (GGTase1)
por: Thippanna, Mallikarjuna, et al.
Publicado: (2013) -
Molecular Dynamics of Rab7::REP1::GGTase-II Ternary Complex and Identification of Their Putative Drug Binding Sites
por: Sindhu, Meenakshi, et al.
Publicado: (2013)